HI
PFE icon

Human Investing’s Pfizer PFE Stock Holding History

Human Investing’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,200
Closed -$84.9K – 204
2024
Q4 		$84.9K Buy
+3,200
New +$86.8K 0.02% 118
2023
Q4 		– Sell
-17,348
Closed -$575K – 100
2023
Q3 		$575K Sell
17,348
-1,707
-9% -$60.4K 0.13% 57
2023
Q2 		$699K Sell
19,055
-8,478
-31% -$330K 0.16% 55
2023
Q1 		$1.12M Sell
27,533
-5,069
-16% -$219K 0.27% 39
2022
Q4 		$1.67M Sell
32,602
-8,082
-20% -$387K 0.43% 30
2022
Q3 		$1.78M Sell
40,684
-1,145
-3% -$55.6K 0.45% 31
2022
Q2 		$2.19M Sell
41,829
-1,623
-4% -$82.7K 0.53% 26
2022
Q1 		$2.25M Sell
43,452
-7,096
-14% -$368K 0.5% 27
2021
Q4 		$2.98M Sell
50,548
-358
-0.7% -$17.7K 0.71% 23
2021
Q3 		$2.19M Sell
50,906
-509
-1% -$22.5K 0.52% 31
2021
Q2 		$2.01M Buy
51,415
+2,425
+5% +$94.3K 0.49% 34
2021
Q1 		$1.77M Buy
48,990
+3,280
+7% +$116K 0.45% 34
2020
Q4 		$1.68M Sell
45,710
-3,345
-7% -$123K 0.48% 37
2020
Q3 		$1.71M Sell
49,055
-1,188
-2% -$41.7K 0.56% 40
2020
Q2 		$1.56M Sell
50,243
-1,270
-2% -$43.1K 0.55% 47
2020
Q1 		$1.59M Sell
51,513
-3,662
-7% -$125K 0.69% 34
2019
Q4 		$2.05M Sell
55,175
-373
-0.7% -$13.3K 0.67% 39
2019
Q3 		$1.89M Sell
55,548
-1,471
-3% -$53.5K 0.67% 40
2019
Q2 		$2.34M Sell
57,019
-1,841
-3% -$73.1K 0.86% 26
2019
Q1 		$2.37M Sell
58,860
-3,186
-5% -$128K 0.89% 31
2018
Q4 		$2.57M Buy
+62,046
New +$2.58M 1.07% 22

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Human Investing's PFE Position: Q1 2025 in Review

Human Investing sold out of Pfizer (PFE) in Q1 2025, closing a stake of 3,200 shares — an estimated $84.9K sold.

Human Investing first reported a position in PFE in Q4 2018 and held it in 21 quarters. The position peaked at $2.98M in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Human Investing reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Human Investing sold 3,200 Pfizer shares in Q1 2025, an estimated $84.9K.
  • Human Investing first reported a position in Pfizer in Q4 2018 and held it in 21 quarters.
  • Human Investing's Pfizer position peaked at $2.98M in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Human Investing's 13F filing for Q1 2025, filed 15 May 2025.